Ramírez-Pineda, José R <br/><br/>
Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  May 2004 
 - 6281-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.172.10.6281  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adoptive Transfer<br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Antigens, Protozoan--pharmacology<br/>Bone Marrow Cells--immunology<br/>CD40 Antigens--immunology<br/>CpG Islands--immunology<br/>Dendritic Cells--immunology<br/>Female<br/>Immunity, Active<br/>Immunity, Innate--genetics<br/>Injections, Intravenous<br/>Injections, Subcutaneous<br/>Interleukin-12--biosynthesis<br/>Intracellular Fluid--immunology<br/>Leishmania major--immunology<br/>Leishmaniasis, Cutaneous--immunology<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Oligodeoxyribonucleotides--administration & dosage<br/>Protozoan Vaccines--administration & dosage<br/>Th1 Cells--immunology<br/>Tumor Necrosis Factor-alpha--pharmacology